Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Social Attention in ASD and TD Children

6 de mayo de 2026 actualizado por: Shan Gao, University of Electronic Science and Technology of China

Dynamic Gaze Strategies in ASD Children During Social Interactions: An Eye-Tracking Investigation Under Intention-Congruent and -Incongruent Conditions

To examine whether the spatiotemporal organization of gaze strategies differs between children with autism spectrum disorder (ASD) and typically developing (TD) children during a staged joint attention interaction, and to identify at which phase differences emerge.

Descripción general del estudio

Descripción detallada

This cross-sectional observational study involved children with ASD and their typically developing (TD) peers freely viewing dynamic social interaction videos. The videos were segmented into four theory-driven phases: Introduction (scene establishment), Joint Attention (mapping another's gaze to an object preference), Intentional Comprehension (inferring the model's intention), and Emotional Feedback (evaluating outcomes that were either congruent or incongruent with the established preference). Participants' eye movements were recorded throughout using a remote eye-tracker.

Tipo de estudio

De observación

Inscripción (Actual)

66

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Sichuan
      • Chengdu, Sichuan, Porcelana, 611731
        • School of Foreign Languages, University of Electronic Science and Technology of China

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño

Acepta Voluntarios Saludables

Sí

Método de muestreo

Muestra no probabilística

Población de estudio

Children with Autism Spectrum Disorder (ASD) and typically developing (TD) peers. ASD participants were recruited from a institution in Chengdu, China; TD participants were recruited from a local kindergarten. The sample covers an age range of approximately 2 to 10 years and includes both males and females, all of whom completed an eye-tracking free-viewing task of social interaction videos.

Descripción

Inclusion Criteria:

- For ASD group: confirmed clinical diagnosis of Autism Spectrum Disorder. For TD group: Typically developing children without any developmental or neurological disorders.

Both groups: Normal or corrected-to-normal vision, no color vision deficiencies, and legal guardian provided written informed consent.

Exclusion Criteria:

- Failure to meet the study's group-specific screening cutoffs on the Social Responsiveness Scale (SRS) and Social Communication Questionnaire (SCQ) Known genetic syndromes, significant hearing loss, or uncorrectable visual impairment

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Autism Spectrum Disorder (ASD) Group
Typically Developing (TD) Group

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Percentage of Total Fixation Duration on Human Faces during Entire Video
Periodo de tiempo: During the full 27-second video presentation
Percentage of total fixation duration on human faces was calculated as (total fixation duration on all face areas of interest / total fixation duration on the entire video) × 100. Fixation was defined as gaze maintained within a 1° visual angle for a minimum of 100 ms. This measure was compared between the ASD and TD groups.
During the full 27-second video presentation
Total Fixation Duration on Human Faces during Entire Video
Periodo de tiempo: During the full 27-second video presentation
Total fixation duration (in milliseconds) on human faces, calculated as the sum of all fixation durations that fell within face areas of interest (AOIs). This measure was compared between the ASD and TD groups.
During the full 27-second video presentation
Percentage of Total Fixation Duration on Human Faces During Phase 4 (Emotional Feedback) by Condition
Periodo de tiempo: During seconds 22-27 of the video
Percentage of fixation duration on faces was calculated for the emotional feedback phase separately for Preference-congruent and Preference-incongruent trials. The interaction between Group (ASD vs. TD) and Condition (Congruent vs. Incongruent) was examined. Higher percentages indicate greater allocation of visual attention to faces during emotional feedback.
During seconds 22-27 of the video
Total Scanpath Length During Entire Video
Periodo de tiempo: During the full 27-second video presentation
During the full 27-second video presentation
Number of Gaze Shifts Between Face and Object Areas of Interest
Periodo de tiempo: During the full 27-second video presentation
The number of saccadic gaze shifts that cross between pre-defined face and object areas of interest (AOIs) was counted. This was taken as an index of attentional switching between social and non-social information.
During the full 27-second video presentation
Mean Distance of Fixation Points from the Center of the Face Area of Interest
Periodo de tiempo: During the full 27-second video presentation
For each fixation, the Euclidean distance (in degrees of visual angle) from its location to the centroid of the pre-defined face AOI was calculated. The mean of these distances across all fixations was then computed. Larger values indicate that gaze tended to fall farther from the faces, reflecting less attention to facial information.
During the full 27-second video presentation

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

22 de julio de 2024

Finalización primaria (Actual)

27 de marzo de 2026

Finalización del estudio (Actual)

27 de marzo de 2026

Fechas de registro del estudio

Enviado por primera vez

6 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

6 de mayo de 2026

Publicado por primera vez (Actual)

13 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

13 de mayo de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

6 de mayo de 2026

Última verificación

1 de mayo de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir